PROTECHT Score (Cancer-Associated VTE Risk)
PROTECHT Score (Cancer-Associated VTE Risk) - a deterministic tool in Sophie Well's Clinical Scoring & Risk group.
Open the PROTECHT Score (Cancer-Associated VTE Risk) → Runs in your browser. No signup, no tracking.
What this is
PROTECHT Score (Cancer-Associated VTE Risk) is one of 230 deterministic tools in Sophie Well's Clinical Scoring & Risk group. PROTECHT Score (Cancer-Associated VTE Risk) - a deterministic tool in Sophie Well's Clinical Scoring & Risk group.
When to use it
Use this tool when you need a quick, citable reference. Every calculation runs entirely in your browser - no inputs leave your device, no account is required, no AI is involved. The site enforces a strict Content Security Policy and ships no analytics or third-party CDN.
References
Verso M, Agnelli G, Barni S, Gasparini G, LaBianca R. A modified Khorana risk assessment score for venous thromboembolism in cancer patients receiving chemotherapy: the PROTECHT score. Intern Emerg Med. 2012;7(4):291-292. Read the source ↗
Worked example: PROTECHT score 4 — high VTE risk (>= 3).
Sophie Well is a reference and educational tool. Not medical, legal, or financial advice. Does not replace clinician judgment, professional billing review, or legal counsel.